Efficacy of sildenafil citrate in treatment of erectile dysfunction: Effect of type 2 diabetes

European Urology

Volumn 46, Issue 4, 2004, Pages 503-509

  El Sakka, Ahmed I ^a,b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b AL NOOR SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

Erectile dysfunction; Sildenafil; Type 2 diabetes

Indexed keywords

PROLACTIN; SILDENAFIL; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; ERECTILE DYSFUNCTION; FUNCTIONAL ASSESSMENT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; SCREENING; TESTOSTERONE BLOOD LEVEL;

ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 2; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 4444282579     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.06.005     Document Type: Article

References (27)

1. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., McKinlay J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151:1994;54-61
2. Rendell MS, Rajfer J, Wicker PA, Smith MD., Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999;281421-6.
3. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. 338(20):1998;1397-1404
4. Boolell M., Gepi-Attee S., Gingell J.C., Allen M.J. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br. J. Urol. 78(2):1996;257-261
5. Steers W.D. Viagra after one year. Urology. 54(1):1999;12-17
6. El-Sakka A.I., Tayeb K.A. Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. J. Urol. 169:2003;1043-1047
7. El-Sakka A.I. Characteristics of erectile dysfunction in Saudi patients. Int. J. Impot. Res. 16:2004;13-20
8. Vandereycken W. Towards a better delineation of ejaculatory disorders. Acta Psychiatrica Belgica. 86:1986;57-63
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington (DC): APA; 1994.
10. Chew K.K., Earle C.M., Stuckey B.G., Jamrozic K., Keogh E.J. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int. J. Impot. Res. 12:2000;41-45
11. Fedele D., Bortolotti A., Coscelli C., Santeusanio F., Chatenoud L., Colli E., et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int. J. Epidemiol. 29:2000;524-531
12. Saenz de Tejada I., Goldstein I. Diabetic penile neuropathy. Urol. Clin. North Am. 15:1988;17-22
13. El-Sakka A.I., Lin C.S., Chui R.M., Dahiya R., Lue T.F. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int. J. Impot. Res. 11:1999;123-132
14. Rehman J., Chenven E., Brink P., Peterson B., Walcott B., Wen Y.P., et al. Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am. J. Physiol. 272:1997;H1960-H1971
15. Klein R., Klein B.E., Lee K.E., Moss S.E., Cruickshanks K.J. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care. 19(2):1996;135-141
16. Seftel A.D., Vaziri N.D., Ni Z., Razmjouei K., Fogarty J., Hampel N., et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology. 50(6):1997;1016-1026
17. Saenz de Tejada I., Goldstein I., Azadzoi K., Krane R.J., Cohen R.A. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N. Engl. J. Med. 320(16):1989;1025-1030
18. Romeo J.H., Seftel A.D., Madhun Z.T., Aron D.C. Sexual function in men with diabetes type 2: association with glycemic control. J. Urol. 163(3):2000;788-791
19. Keene L.C., Davies P.H. Drug-related erectile dysfunction. Adverse Drug React Toxicol. Rev. 18(1):1999;5-24
20. Boulton AJM, Ziegler D, Sweeney M. The first study of sildenafil for erectile dysfunction in men with type 2 diabetes mellitus. Presented at the American Diabetes Association Meeting. June 9-13, 2000, San Antonio, TX.
21. Hirsch IB, Korenman SG, Stecher V, Diuguid C. Viagra (sildenafil citrate ) efficacy and safety in the treatment of erectile dysfunction (ED) in men with diabetes. Presented at the American Diabetes Association Meeting. June 19-22, 1999, San Diego, CA.
22. Price D.E., Gingell J.C., Gepi-Attee S., Wareham K., Yates P., Boolell M. Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet. Med. 15(10):1998;821-825
23. Boulton A.J., Selam J.L., Sweeney M., Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia. 44(10):2001;1296-1301
24. Guay A.T., Blonde L., Siegel R., et al. Safty and tolerability of sildenafil citrate for treatment of erectile dysfunction in men.with type 1 and type 2 diabetes mellitus. Diabetes. 49(Suppl 1):2000;363
25. Bemelmans B.L., Meuleman E.J., Doesburg W.H., Notermans S.L., Debruyne F.M. Erectile dysfunction in diabetic men: the neurological factor revisited. J. Urol. 151(4):1994;884-889
26. Kadioglu A., Erdogru T., Karsidag K., Dinccag N., Satman I., Yilmaz M.T., et al. Evaluation of penile arterial system with color Doppler ultrasonography in nondiabetic and diabetic males. Eur. Urol. 27(4):1995;311-314
27. El-Sakka A.I. Penile axial rigidity and Doppler ultrasonography parameters in patients with erectile dysfunction: association with type 2 diabetes. Urology. 62(3):2003;525-531